Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Barbara Kreppel
Observed names:
B Kreppel,
B. Kreppel,
Barbara Schmidt-Kreppel,
Kreppel, B.,
Kreppel, Barbara
Institutions:
University Hospital Bonn,
Klinik und Poliklinik für Nuklearmedizin
Observed institutions:
University of Bonn,
University of Cologne,
University Hospital Bonn,
Klinik und Poliklinik für Nuklearmedizin
ORCID:
0009-0004-0097-2296
Observed ORCID:
0009-0004-0097-2296
OpenAlex ID:
A5080172290
Clinical Translation and First In-Human Use of [44Sc]Sc-PSMA-617 for PET Imaging of Metastasized Castrate-Resistant Prostate Cancer
2017
·
Elisabeth Eppard
, Ana de la Fuente
, et al.
·
Theranostics
·
145
PDF
Podoplanin expression in cutaneous head and neck squamous cell carcinoma—prognostic value and clinicopathologic implications
2012
·
Matthias Kreppel
, Anton Krakowezki
, et al.
·
Journal of Surgical Oncology
·
40
Podoplanin expression in oral leukoplakia: prognostic value and clinicopathological implications
2012
·
M Kreppel
, B Kreppel
, et al.
·
Oral Diseases
·
40
Fibroblast activation protein inhibitor (FAPi) positive tumour fraction on PET/CT correlates with Ki-67 in liver metastases of neuroendocrine tumours
2021
·
Barbara Kreppel
, Maria Angeles Gonzalez-Carmona
, et al.
·
Nuklearmedizin - NuclearMedicine
·
26
[68Ga]Ga-DATA5m.SA.FAPi PET/CT: Specific Tracer-uptake in Focal Nodular Hyperplasia and potential Role in Liver Tumor Imaging
2020
·
Barbara Kreppel
, Florian C. Gärtner
, et al.
·
Nuklearmedizin - NuclearMedicine
·
22
Case Report: Sustained complete remission on combination therapy with olaparib and pembrolizumab in BRCA2-mutated and PD-L1-positive metastatic cholangiocarcinoma after platinum derivate
2022
·
Taotao Zhou
, Robert Mahn
, et al.
·
Frontiers in Oncology
·
18
Clinical evaluation of [68Ga]Ga-DATA-TOC in comparison to [68Ga]Ga-DOTA-TOC in patients with neuroendocrine tumours
2019
·
F.C. Gaertner
, T. Plum
, et al.
·
Nuclear Medicine and Biology
·
11
PDF
[177Lu]Lu-DOTA-zoledronate therapy – first application in a patient with primary osseous metastatic bronchial carcinoma
2020
·
Barbara Kreppel
, Florian Christoph Gaertner
, et al.
·
Nuklearmedizin - NuclearMedicine
·
8
PET-CT bei Karzinomen im Kopf‑Hals‑Bereich
2017
·
T. Send
, B. Kreppel
, et al.
·
HNO
·
7
Bellmunt risk score enables survival prediction in men with metastatic castration resistant prostate cancer (mCRPC) undergoing PSMA-targeted radioligand therapy (LUMEN)
2025
·
Thomas Büttner
, Milka Marinova
, et al.
·
European Journal of Nuclear Medicine and Molecular Imaging
·
4
PDF
PET / CT surveillance versus neck dissection in advanced head and neck cancer
2016
·
M Kreppel
, B Kreppel
, et al.
·
Oral Diseases
·
3
Quantifying the Renal Impact of [ 177 Lu]Lu-PSMA-617: A Longitudinal Analysis of Real-World Data from the LUMEN Registry
2026
·
Thomas Büttner
, Christian Hoffmann
, et al.
·
Journal of Nuclear Medicine
·
2
PDF
Prognostic Significance of CD68+ Macrophages and FoxP3+ Regulatory T Cells in Neuroendocrine Tumors
2025
·
Markus Essler
, Glen Kristiansen
, et al.
·
Nuklearmedizin - NuclearMedicine
·
2
Regulation of PDL-1 expression in thyroid carcinoma cells by tumor cell derived cytokines activating STAT3
2024
·
Matthias Klemke
, Nadine Veit
, et al.
·
Immunologic Research
·
2
PDF
Safety and patient-reported outcomes of multimodal PSMA PET/MRI-guided prostate biopsy: results from the prospective multicenter DEPROMP trial
2026
·
Clarissa Julia Schmidt
, Tim Reichert
, et al.
·
World Journal of Urology
·
1
PDF
Segment‐based comparison of multiparametric MRI , Gallium‐68‐ PSMA ‐ PET / CT and combined imaging with histopathology in prostate cancer
2026
·
Clarissa J. Schmidt
, Marit Bernhardt
, et al.
·
British Journal of Urology
PDF
Immunogenic cell death as a mechanism of synergy between sunitinib and 177Lu-DOTATATE peptide receptor radionuclide therapy in pancreatic neuroendocrine tumors
2026
·
Markus Essler
, Nadine Veit
, et al.
·
Cell Death Discovery
PDF
Skeletal muscle radiodensity as an automated survival predictor in men with metastatic castration-resistant prostate cancer undergoing PSMA-targeted radioligand therapy
2026
·
Christian Immanuel
, Thomas Büttner
, et al.
·
European Journal of Nuclear Medicine and Molecular Imaging
PDF
External validation of the P-Score in the prospective, pre-biopsy DEPROMP cohort: integrated mpMRI and PSMA PET/CT risk stratification for prostate cancer detection
2026
·
Clarissa Julia Schmidt
, Florian C Gaertner
, et al.
·
European Journal of Nuclear Medicine and Molecular Imaging
PDF
Nichtinvasive Prädiktion des PTEN-Status und der PSMA-Expression mittels mpMRT und ⁶⁸Ga-PSMA-PET/CT beim primären Prostatakarzinom
2026
·
Schmidt, Clarissa Julia
, Bernhardt, M.
, et al.
·
German Medical Science (German Research Foundation)
Konkordanz der Prostatakarzinomausdehnung zwischen MRT, PSMA-PET/CT und Histopathologie
2026
·
Schmidt, Clarissa J.
, Bernhardt, Marit
, et al.
·
German Medical Science (German Research Foundation)
Nectin-4-PET/CT mit [⁶⁸Ga]Ga-N188 zur Darstellung der Nectin-4-Expression beim metastasierten Urothelkarzinom unter Enfortumab vedotin + Pembrolizumab
2026
·
Krausewitz, Philipp
, Muench, Gloria
, et al.
·
German Medical Science (German Research Foundation)
Radiogenomische Korrelation des PTEN-Status und der PSMA-Expression mit multiparametrischer MRT und ⁶⁸Ga-PSMA-PET/CT beim primären Prostatakarzinom
2026
·
Schmidt, Clarissa J.
, Bernhardt, Marit
, et al.
·
German Medical Science (German Research Foundation)
Quantifizierung der Nephrotoxizität von [177Lu]Lu-PSMA-617: eine Längsschnittanalyse des Real-World LUMEN-Registers
2026
·
Büttner, Thomas
, Hoffmann, Christian
, et al.
·
German Medical Science (German Research Foundation)
Externe Validierung des P-Scores im DEPROMP-Studienkollektiv: optimierte Detektion klinisch signifikanter Prostatakarzinome durch MRT und PSMA-PET/CT
2026
·
Schmidt, Clarissa J.
, Gärtner, Florian C.
, et al.
·
German Medical Science (German Research Foundation)
Show more works
View as search
Works count:
39
Citation count:
356
H-index:
8
I10-index:
8
Year
Topic
Type